|
Diphosphotransferases
|
D08.811.913.696.175 |
|
|
Phosphotransferases
|
D08.811.913.696 |
|
|
Receptor, Adenosine A2B
|
D12.776.543.750.720.700.700.200.200 |
|
|
Receptors, Adenosine A2
|
D12.776.543.750.720.700.700.200 |
|
|
Hair Cells, Auditory, Outer
|
A08.675.650.250.315 |
|
|
Hair Cells, Auditory
|
A08.675.650.250 |
|
|
Lyases
|
D08.811.520 |
|
|
Enzymes
|
D08.811 |
|
|
SLC31 Proteins
|
D12.776.157.530.450.250.578.875 |
|
|
Copper Transport Proteins
|
D12.776.157.530.450.250.578 |
|
|
Aflatoxin B1
|
D03.383.663.283.119.075 |
|
|
Aflatoxins
|
D03.383.663.283.119 |
|
|
Pachytene Stage
|
G04.144.220.220.781.906.750 |
|
|
Prophase
|
G04.144.220.220.781.906 |
|
|
Desmoglein 2
|
D23.050.301.350.200.500.500.625 |
|
|
Desmogleins
|
D23.050.301.350.200.500.500 |
|
|
Designer Drugs
|
D015198 |
[Drugs designed and synthesized, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are MPTP (a reverse ester of meperidine), MDA (3,4-methylenedioxyamphetamine), and MDMA (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines.
] |
|
Extracorporeal Membrane Oxygenation
|
D015199 |
[Application of a life support system that circulates the blood through an oxygenating system, which may consist of a pump, a membrane oxygenator, and a heat exchanger. Examples of its use are to assist victims of SMOKE INHALATION INJURY; RESPIRATORY FAILURE; and CARDIAC FAILURE.
] |
|
G-Protein-Coupled Receptor Kinases
|
D054768 |
[A family of serine-threonine kinases that are specific for G-PROTEIN-COUPLED RECEPTORS. They are regulatory proteins that play a role in G-protein-coupled receptor densensitization.
] |
|
Thiogalactosides
|
D09.408.903.600 |
|
